67728-1-Ig

antibody from Proteintech Group

Targeting: TXNRD1 GRIM-12, Trxr1, TXNR

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

67728-1-Ig

Provider

Proteintech Group

Product name

TXNRD1 antibody

Antibody type

Monoclonal

Description

TXNRD1 antibody (Cat. #67728-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, mouse, rat and has been validated for the following applications: IF, IHC, WB,ELISA.

Reactivity

Human, Mouse, Rat

Host

Mouse

Conjugate

Unconjugated

Isotype

IgG

Antibody clone number

1B10C4

Vial size

20ul, 150ul

References

Submitted references

Identification of PRDX5 as A Target for The Treatment of Castration-Resistant Prostate Cancer.

Wang R, Mi Y, Ni J, Wang Y, Ding L, Ran X, Sun Q, Tan SY, Koeffler HP, Feng N, Chen YQ
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024 Mar;11(9):e2304939

---

Benzophenanthridine Alkaloid Chelerythrine Elicits Necroptosis of Gastric Cancer Cells via Selective Conjugation at the Redox Hyperreactive C-Terminal Sec(498) Residue of Cytosolic Selenoprotein Thioredoxin Reductase.

Liu M, Sun S, Meng Y, Wang L, Liu H, Shi W, Zhang Q, Xu W, Sun B, Xu J
Molecules (Basel, Switzerland) 2023 Sep 28;28(19)

---

Nitrovin (difurazone), an antibacterial growth promoter, induces ROS-mediated paraptosis-like cell death by targeting thioredoxin reductase 1 (TrxR1).

Zhao L, Zhong B, Zhu Y, Zheng H, Wang X, Hou Y, Lu JJ, Ai N, Guo X, Ge W, Ma YY, Chen X
Biochemical pharmacology 2023 Apr;210:115487

---

Deletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function.

Stancill JS, Hansen PA, Mathison AJ, Schmidt EE, Corbett JA
Function (Oxford, England) 2022;3(4):zqac034

---

A multifaceted and feasible prognostic model of amino acid metabolism-related genes in the immune response and tumor microenvironment of head and neck squamous cell carcinomas.

Li W, Zou Z, An N, Wang M, Liu X, Mei Z
Frontiers in oncology 2022;12:996222

---

Bioinformatics-Driven Identification of p62 as A Crucial Oncogene in Liver Cancer.

Wang L, Hensley CR, Howell ME, Ning S
Frontiers in oncology 2022;12:923009

---

Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis.

Guo W, Wu Z, Chen J, Guo S, You W, Wang S, Ma J, Wang H, Wang X, Wang H, Ma J, Yang Y, Tian Y, Shi Q, Gao T, Yi X, Li C
Journal for immunotherapy of cancer 2022 Jun;10(6)

---

Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma.

Xu Z, Xu J, Sun S, Lin W, Li Y, Lu Q, Li F, Yang Z, Lu Y, Liu W
Redox biology 2022 Aug;54:102351

---

A Robust Metabolic Enzyme-Based Prognostic Signature for Head and Neck Squamous Cell Carcinoma.

Mai Z, Chen H, Huang M, Zhao X, Cui L
Frontiers in oncology 2021;11:770241

---

Protein S-nitrosylation regulates proteostasis and viability of hematopoietic stem cell during regeneration.

Yi W, Zhang Y, Liu B, Zhou Y, Liao D, Qiao X, Gao D, Xie T, Yao Q, Zhang Y, Qiu Y, Huang G, Chen Z, Chen C, Ju Z
Cell reports 2021 Mar 30;34(13):108922